Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omadacycline in Female Adults With Cystitis
NCT03425396Phase 2Completed
- Sponsor
- Paratek Pharmaceuticals
- Start
- Jan 2018
- Primary completion
- May 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omadacycline in cystitis, sponsored by Paratek Pharmaceuticals. Started Jan 2018; status: completed.
02
Drugs
omadacycline
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT03425396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03425396.